Last reviewed: June 25, 2026
Last updated: June 25, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide at the maximum maintenance dose of 2.4 mg produces significant weight loss in clinical trials, with average reductions of 15% body weight at 68 weeks in the landmark STEP trial. Individual results vary based on genetics, lifestyle, and how your body responds to GLP-1 receptor stimulation. PlexusDx provides access to compounded semaglutide injections starting at $149 per month, allowing you to find your optimal dose without price increases as you progress.
Expected Weight Loss on 2.4 mg Semaglutide Injections
Clinical trial data shows adults taking semaglutide 2.4 mg weekly lose between 10% and 22% of their starting body weight when combined with lifestyle changes. For someone weighing 250 pounds, this translates to 25–55 pounds of loss over six months. The largest reductions typically occur in the first 12–16 weeks as your body adapts to appetite suppression and improved glucose metabolism. Weight loss continues gradually through month six and often stabilizes thereafter, though some individuals experience additional loss in months seven through twelve.
Results depend heavily on individual factors including your baseline metabolic rate, adherence to reduced calorie intake, physical activity level, and genetic predisposition to GLP-1 responsiveness. Two people at identical starting weights may lose different amounts even on the same dose, reflecting natural variation in peptide pathway activation. PlexusDx offers optional Precision Peptide Genetic Testing ($99 add-on after your first month) to map your GLP1R, GIPR, FTO, and MC4R variants across 14 metabolic pathways, helping predict your likely response category before you start treatment.
Timeline: When You'll See Results on Semaglutide
Most patients notice appetite reduction and early weight loss within the first two to three weeks of starting semaglutide, though the starting dose is typically much lower than the 2.4 mg maximum. You'll follow a titration schedule, increasing your dose every four weeks (0.25 mg → 0.5 mg → 1 mg → 1.7 mg → 2.4 mg) to minimize nausea and allow your body to adapt. Meaningful weight loss—usually two to five pounds—becomes visible by week four to six, with momentum accelerating as you reach the 1 mg and 1.7 mg doses around weeks eight through twelve.
The plateau phase typically arrives around week 16–20, where weight loss slows but does not stop entirely. Many patients continue losing one to two pounds per week at the maintenance dose of 2.4 mg through month six. After six months, your body may reach a new equilibrium weight while you remain on the medication; stopping semaglutide often leads to weight regain within weeks. PlexusDx patients can adjust their dosing strategy at any point—staying at a lower effective dose, increasing to 2.4 mg, or switching to dual-compound GLP-Squared injections if plateauing occurs.
Factors That Influence Your Individual Weight Loss
Genetics play a measurable role in semaglutide response. The GLP1R rs6923761 genetic variant affects how efficiently your GLP-1 receptors bind to semaglutide molecules; individuals carrying the T allele may show enhanced appetite suppression at lower doses. The GIPR rs1800437 variant influences glucose-dependent insulin secretion, affecting how much of your weight loss comes from reduced hunger versus improved metabolic control. The FTO rs9939609 variant (associated with increased hunger hormone levels) may predict whether you benefit most from maximum-dose semaglutide or a dual-compound approach like GLP-Squared.
Non-genetic factors are equally critical: calorie deficit maintenance, protein intake during meals, consistent weekly injection timing, sleep quality, stress levels, and physical activity all modulate your results significantly. Patients who continue eating high-sugar, processed foods often experience slower weight loss despite appetite suppression. Conversely, individuals who align semaglutide with structured dietary changes (high protein, whole foods, lower refined carbs) frequently exceed average trial outcomes. Alcohol consumption, certain medications, and thyroid function also influence the rate of fat loss.
Semaglutide 2.4 mg Versus Compounded Alternatives at PlexusDx
PlexusDx offers three semaglutide delivery options: compounded semaglutide injections (starting at $149/mo), oral semaglutide (starting at $249/mo), and GLP-Squared injections combining semaglutide with tirzepatide for dual-pathway stimulation (starting at $249/mo). All injectable forms begin at the lowest dose and titrate upward; your dose may need to go up over weeks, but your price will not increase. Injectable semaglutide typically produces faster and more dramatic appetite suppression than oral semaglutide, with better gastrointestinal tolerability because the medication bypasses the stomach lining initially.
If you plateau on semaglutide alone or experience diminishing returns after three to four months, switching to GLP-Squared injections activates both GLP-1 and GIP receptors simultaneously, often restoring or exceeding weight loss momentum. PlexusDx compounds all medications from licensed 503A pharmacies serving all 50 states with no insurance requirement, no membership fees, and full HSA/FSA eligibility. The optional Precision Peptide Genetic Test ($99) analyzes 150+ genetic insights across your peptide pathways to guide whether semaglutide solo, tirzepatide, or the dual compound is your best match.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I lose 20+ pounds on semaglutide 2.4 mg in three months?
Most patients lose 10–15 pounds in the first three months because they're still titrating upward through lower doses. Once you reach 2.4 mg (typically week 12–16), the rate of loss often accelerates, with many people reaching 20+ pounds total by month six. The timing depends on your starting weight, baseline metabolism, and how strictly you maintain a calorie deficit alongside the medication.
What does clinical trial data actually show for semaglutide weight loss?
The STEP 1 trial (the primary efficacy study) showed adults on semaglutide 2.4 mg plus lifestyle intervention lost an average of 15% of body weight (approximately 35 pounds) over 68 weeks compared to 2.6% loss in the placebo group. Approximately 50% of participants achieved weight loss of 15% or more, while 35% lost 20% or more, demonstrating substantial individual variation in response.
How much does semaglutide cost at PlexusDx, and do prices increase if I need a higher dose?
PlexusDx compounded semaglutide injections start at $149 per month flat—your dose may need to go up, but your price will not. All medications are compounded at licensed 503A pharmacies, available across all 50 states with no insurance needed, no membership fees, and full HSA/FSA eligibility.
What are the most common side effects, and do they prevent weight loss?
Nausea, vomiting, constipation, and reduced appetite are typical during the dose escalation phase and usually resolve within one to two weeks at each new dose level. These side effects do not prevent weight loss; in fact, appetite suppression is the mechanism that drives it. Staying hydrated, eating small frequent meals, and slowing your dose titration if needed helps minimize discomfort without sacrificing results.
How can genetic testing help predict my semaglutide weight loss?
PlexusDx Precision Peptide Genetic Testing ($99 add-on) identifies your GLP1R, GIPR, FTO, and MC4R variants across 14 metabolic pathways and 150+ genetic insights, predicting whether you're likely a robust responder, moderate responder, or may benefit from dual-compound therapy like GLP-Squared before you invest weeks in a single medication.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Pain Relief: Can I Take Ibuprofen on Ozempic During Your Weight Loss Journey?
Mastering Your Weight Loss Journey: Where Can I Take the Ozempic Shot?